XML 44 R34.htm IDEA: XBRL DOCUMENT v3.21.2
STOCKHOLDERS’ DEFICIT (Details Narrative) - USD ($)
3 Months Ended 6 Months Ended 9 Months Ended
Aug. 10, 2021
Jul. 26, 2021
May 26, 2021
Apr. 29, 2021
Feb. 25, 2021
Feb. 25, 2020
Jan. 02, 2017
Sep. 30, 2021
Jun. 30, 2021
Mar. 31, 2021
Sep. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Dec. 31, 2020
Subsidiary, Sale of Stock [Line Items]                                
Proceeds from Issuance Initial Public Offering       $ 11,700,000                        
Stock options outstanding               5,530,861           5,530,861   5,597,861
Stock options outstanding weighted average exercise price               $ 1.84           $ 1.84   $ 1.47
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value               $ 1,837,818           $ 1,837,818    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross                           583,000    
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price                           $ 4.77    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term                           6 years 5 months 23 days    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares                           540,104    
Stock issued during the period exercised                 360,000         370,000    
Commom stock issued               16,955,817 360,000     360,000   16,955,817   10,360,480
Proceeds from Stock Options Exercised                 $ 532,500              
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number               6,132,630           6,132,630   4,007,058
Warrants outstanding                 836,558 240,123   836,558        
Proceeds from warrants exercised                 $ 300,000              
Options To Related Party [Member]                                
Subsidiary, Sale of Stock [Line Items]                                
Stock options outstanding                 10,000     10,000        
Stock options outstanding weighted average exercise price               $ 1.00           $ 1.00    
Stock issued during the period exercised                           10,000    
Warrants outstanding                 231,277     231,277        
2016 Plan [Member]                                
Subsidiary, Sale of Stock [Line Items]                                
Number of additional shares grants for issuance             564,378                  
Number of shares available for grant             1,693,134 4,868,623           4,868,623   4,868,623
Series B Prefered Stock [Member]                                
Subsidiary, Sale of Stock [Line Items]                                
Preferred Stock, Convertible, Shares Issuable               872,766           872,766    
Common Stock [Member]                                
Subsidiary, Sale of Stock [Line Items]                                
Preferred Stock, Convertible, Shares Issuable               872,766           872,766    
Employees [Member]                                
Subsidiary, Sale of Stock [Line Items]                                
Share-based Payment Arrangement, Expense               $ 53,966                
Unamortized stock option expense               289,828           $ 289,828    
Non-Employees [Member]                                
Subsidiary, Sale of Stock [Line Items]                                
Share-based Payment Arrangement, Expense                     $ 177,683     582,224    
Unamortized stock option expense               2,095,218           2,095,218    
Share-based Payment Arrangement, Option [Member]                                
Subsidiary, Sale of Stock [Line Items]                                
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross                       583,000        
Share-based Payment Arrangement, Expense               231,649     458,567   $ 1,762,495 718,366    
Share-based Payment Arrangement, Option [Member] | Settlement of Accrued Compensation [Member]                                
Subsidiary, Sale of Stock [Line Items]                                
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 5,000 32,000 180,000                          
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price $ 1.96 $ 2.09 $ 3.65     $ 5.60                    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value $ 9,615 $ 65,626 $ 474,231     $ 2,009,063                    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term 10 years 10 years 10 years                          
Share-based Payment Arrangement, Option [Member] | Options Vested Over 48 Months [Member]                                
Subsidiary, Sale of Stock [Line Items]                                
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares         16,000                      
Share-based Payment Arrangement, Option [Member] | General and Administrative Expense [Member]                                
Subsidiary, Sale of Stock [Line Items]                                
Share-based Payment Arrangement, Expense               230,173     458,091     1,296,162 $ 1,052,294  
Share-based Payment Arrangement, Option [Member] | Research and Development Expense [Member]                                
Subsidiary, Sale of Stock [Line Items]                                
Share-based Payment Arrangement, Expense               1,476     $ 1,476     4,428 $ 70,857  
Share-based Payment Arrangement, Option [Member] | Minimum [Member]                                
Subsidiary, Sale of Stock [Line Items]                                
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price                             $ 1.96  
Share-based Payment Arrangement, Option [Member] | Minimum [Member] | Settlement of Accrued Compensation [Member]                                
Subsidiary, Sale of Stock [Line Items]                                
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term           5 years                    
Share-based Payment Arrangement, Option [Member] | Maximum [Member]                                
Subsidiary, Sale of Stock [Line Items]                                
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price                             $ 5.60  
Share-based Payment Arrangement, Option [Member] | Maximum [Member] | Settlement of Accrued Compensation [Member]                                
Subsidiary, Sale of Stock [Line Items]                                
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term           10 years                    
Share-based Payment Arrangement, Option [Member] | 5 Individuals [Member]                                
Subsidiary, Sale of Stock [Line Items]                                
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross         366,000                      
Share-based Payment Arrangement, Option [Member] | Related Parties [Member]                                
Subsidiary, Sale of Stock [Line Items]                                
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross           350,000                    
Equity Option [Member]                                
Subsidiary, Sale of Stock [Line Items]                                
Share-based Payment Arrangement, Expense                           1,300,590 $ 1,123,151  
Unamortized stock option expense               $ 2,385,046           $ 2,385,046    
Warrant [Member]                                
Subsidiary, Sale of Stock [Line Items]                                
Stock issued during the period exercised                 1,008,137              
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number               6,132,630           6,132,630    
Class of warrant or right, outstanding, weighted average exercise price               $ 3.38           $ 3.38    
Class of warrant or right, outstanding, intrinsic value               $ 2,129,482           $ 2,129,482    
Warrants outstanding                   373,042            
Proceeds from warrants exercised                   $ 27,125            
IPO [Member]                                
Subsidiary, Sale of Stock [Line Items]                                
Stock Issued During Period, Shares, New Issues       3,180,000                        
Class of Warrant or Right, Number of Securities Called by Warrants or Rights       3,180,000                        
IPO [Member] | Underwriter [Member]                                
Subsidiary, Sale of Stock [Line Items]                                
Stock Issued During Period, Shares, New Issues       79,500                        
IPO [Member] | 45-day Option [Member]                                
Subsidiary, Sale of Stock [Line Items]                                
Class of Warrant or Right, Number of Securities Called by Warrants or Rights       477,000